The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms.
Vasomotor symptoms (VMS) are among the most bothersome complaints of postmenopausal women. To date, the most widely studied and effective treatment for VMS is hormone replacement therapy, consisting of estrogen (in women without a uterus) or estrogen plus progestin (in women with a uterus). Traditionally, oral estrogens have been used for treatment. However, over the years, additional estrogen formulations have been developed including transdermal patches; vaginal rings, creams, and tablets; and injectable preparations. Two newer formulations are transdermal estrogen spray and estradiol topical emulsion. This review evaluates the current literature assessing the use of these two newer formulations for the treatment of VMS associated with menopause.
Egras
Amy M
AM
Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA.
Umland
Elena M
EM